Filing metadata

Accession number
0001567619-22-006947
Form type
Form 4
Filer
Eiger BioPharmaceuticals, Inc.
CIK
CIK 1305253
Filed
Mar 14, 2022
Reporting period
Mar 14, 2022
Description
Insider transaction

Explore SEC Filings Hub